Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C11H17NO3 |
Molecular Weight | 211.2576 |
Optical Activity | ( - ) |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)NC[C@H](O)C1=CC=C(O)C(O)=C1
InChI
InChIKey=JWZZKOKVBUJMES-NSHDSACASA-N
InChI=1S/C11H17NO3/c1-7(2)12-6-11(15)8-3-4-9(13)10(14)5-8/h3-5,7,11-15H,6H2,1-2H3/t11-/m0/s1
Molecular Formula | C11H17NO3 |
Molecular Weight | 211.2576 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Levisoprenaline (l-isoproterenol) is beta1- and beta2-adrenoreceptor agonist. In Japan, continuous inhalation of levisoprenaline is a recommended treatment for pediatric patients with acute severe exacerbation. Compared with salbutamol, l-isoproterenol reduced modified pulmonary index score more rapidly. But in most countries do not recommend continuous inhalation of l-isoproterenol to treat pediatric patients with acute severe exacerbation of asthma due to worsening asthma control. Levisoprenaline was used to cause experimental chronic heart failure in rats.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL213 Sources: https://www.ncbi.nlm.nih.gov/pubmed/7562902 |
2.2 nM [EC50] | ||
Target ID: CHEMBL210 Sources: https://www.ncbi.nlm.nih.gov/pubmed/7562902 |
3.0 nM [EC50] |
PubMed
Title | Date | PubMed |
---|---|---|
Method for non-invasively recording electrocardiograms in conscious mice. | 2001 |
|
The hyperpolarization-activated current If in ventricular myocytes of non-transgenic and beta2-adrenoceptor overexpressing mice. | 2001 Aug |
|
(-)-Isoproterenol modulation of maxi-K(+) channel in nonpigmented ciliary epithelial cells through a G-protein gated pathway. | 2002 Mar |
|
Inotropic responses to human gene 2 (B29) relaxin in a rat model of myocardial infarction (MI): effect of pertussis toxin. | 2002 Nov |
|
Cardiostimulant and cardiodepressant effects through overexpressed human beta2-adrenoceptors in murine heart: regional differences and functional role of beta1-adrenoceptors. | 2003 Apr |
|
(-)-CGP 12177 increases contractile force and hastens relaxation of human myocardial preparations through a propranolol-resistant state of the beta 1-adrenoceptor. | 2003 Jan |
|
Enzyme-linked immunosorbent assay development for the beta-adrenergic agonist zilpaterol. | 2004 Apr 21 |
|
Functional serotonin 5-HT4 receptors in porcine and human ventricular myocardium with increased 5-HT4 mRNA in heart failure. | 2004 Sep |
|
Role of NO in the systemic hemodynamic response to beta2-adrenoceptor stimulation. | 2006 Aug |
|
Pharmacological evaluation of plasma membrane beta-adrenoceptors in rat hearts using the tissue segment binding method. | 2006 Aug 1 |
|
Multiple signalling pathways involved in beta2-adrenoceptor-mediated glucose uptake in rat skeletal muscle cells. | 2006 Feb |
|
Catecholamines relax detrusor through beta 2-adrenoceptors in mouse and beta 3-adrenoceptors in man. | 2009 Jan |
|
Phosphodiesterases do not limit beta1-adrenoceptor-mediated sinoatrial tachycardia: evidence with PDE3 and PDE4 in rabbits and PDE1-5 in rats. | 2009 Nov |
|
Receptor-mediated enhancement of beta adrenergic drug activity by ascorbate in vitro and in vivo. | 2010 Dec 13 |
|
The laminin β1-competing peptide YIGSR induces a hypercontractile, hypoproliferative airway smooth muscle phenotype in an animal model of allergic asthma. | 2010 Dec 3 |
|
Beta1-adrenoceptor polymorphism predicts flecainide action in patients with atrial fibrillation. | 2010 Jul 2 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/30846304
10 μg/kg/h for 12 hours
Route of Administration:
Respiratory
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:54:49 GMT 2023
by
admin
on
Fri Dec 15 15:54:49 GMT 2023
|
Record UNII |
588N0603CT
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C319
Created by
admin on Fri Dec 15 15:54:49 GMT 2023 , Edited by admin on Fri Dec 15 15:54:49 GMT 2023
|
||
|
NCI_THESAURUS |
C48149
Created by
admin on Fri Dec 15 15:54:49 GMT 2023 , Edited by admin on Fri Dec 15 15:54:49 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB08460MIG
Created by
admin on Fri Dec 15 15:54:49 GMT 2023 , Edited by admin on Fri Dec 15 15:54:49 GMT 2023
|
PRIMARY | |||
|
51-31-0
Created by
admin on Fri Dec 15 15:54:49 GMT 2023 , Edited by admin on Fri Dec 15 15:54:49 GMT 2023
|
PRIMARY | |||
|
100000082804
Created by
admin on Fri Dec 15 15:54:49 GMT 2023 , Edited by admin on Fri Dec 15 15:54:49 GMT 2023
|
PRIMARY | |||
|
C74197
Created by
admin on Fri Dec 15 15:54:49 GMT 2023 , Edited by admin on Fri Dec 15 15:54:49 GMT 2023
|
PRIMARY | |||
|
864
Created by
admin on Fri Dec 15 15:54:49 GMT 2023 , Edited by admin on Fri Dec 15 15:54:49 GMT 2023
|
PRIMARY | |||
|
2388
Created by
admin on Fri Dec 15 15:54:49 GMT 2023 , Edited by admin on Fri Dec 15 15:54:49 GMT 2023
|
PRIMARY | |||
|
443372
Created by
admin on Fri Dec 15 15:54:49 GMT 2023 , Edited by admin on Fri Dec 15 15:54:49 GMT 2023
|
PRIMARY | |||
|
6257
Created by
admin on Fri Dec 15 15:54:49 GMT 2023 , Edited by admin on Fri Dec 15 15:54:49 GMT 2023
|
PRIMARY | |||
|
588N0603CT
Created by
admin on Fri Dec 15 15:54:49 GMT 2023 , Edited by admin on Fri Dec 15 15:54:49 GMT 2023
|
PRIMARY | |||
|
CHEMBL460574
Created by
admin on Fri Dec 15 15:54:49 GMT 2023 , Edited by admin on Fri Dec 15 15:54:49 GMT 2023
|
PRIMARY | |||
|
DTXSID2043878
Created by
admin on Fri Dec 15 15:54:49 GMT 2023 , Edited by admin on Fri Dec 15 15:54:49 GMT 2023
|
PRIMARY | |||
|
m6533
Created by
admin on Fri Dec 15 15:54:49 GMT 2023 , Edited by admin on Fri Dec 15 15:54:49 GMT 2023
|
PRIMARY | Merck Index |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> AGONIST |
Mouse receptor value
Ki
|
||
|
TARGET -> AGONIST |
Kact cAMP effects in CHO cells expressing human beta-2 receptor.
EC50
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
TARGET -> AGONIST |
Kact cAMP effects Kact cAMP effects in CHO cells expressing human beta-1 receptor.
EC50
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
TARGET -> AGONIST |
Ki
|
||
|
TARGET -> AGONIST |
EC50
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|